ARCHIVES

Tivozanib Trumps Sorafenib In 1st-Line Renal Cancer Study

This article is from The Cancer Letter archive.

Vol. 35 No. 5 | May 25, 2012

Download PDF Visit The Full Archive

Related Articles

Two Workshops To Look For New Research Areas

October 29, 1976

Judah Folkman, Angiogenesis Pioneer, Dead at 74.

January 18, 2008

Congress Asked To Equalize Cuts, Add $20 million For Centers

April 25, 1980

California approves $3 billion program for stem-cell research.

November 5, 2004

Controversy Raging On Whether To Release Data On 5-FU/Levamisole, Stop Untreated Control Arm

June 9, 1989

Response From Center Representatives In L.A. To NCI Questions Is “Frusterating,” DeVita Says

April 13, 1984